GlassScriptPhysician profile
Abdelhamid Hindi
NPI 1083318372
$4,289.14
in general payments reported to CMS, 2019-2025
8 companies · $3,925 in 2025
The $3,925 reported for 2025 was more than what 93% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $364 · 2025: $3,925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,481 · Food and Beverage: $1,808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,481.31 |
| Food and Beverage | $1,807.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,303.93 | 2024-2025 | |
| Alcon Vision LLC | $1,148.86 | 2025 | Hydrus Microstent |
| Glaukos Corporation | $268.49 | 2024-2025 | Idose, Idosetr, Istent Infinite |
| Sight Sciences, INC. | $193.60 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Johnson & Johnson Surgical Vision, INC. | $137.74 | 2025 | Tecnis Iol, Catalys System, Tecnis Simplicity |
| Recordati_rare_diseases_inc. | $123.98 | 2025 | Cystadrops |
| Bausch & Lomb Americas INC. | $95.85 | 2024 | Miebo, Xiidra |
| New World Medical,INC. | $16.69 | 2025 | Clearpath, Kahook Dual Blade, Ahmed Glaucoma Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdelhamid Hindi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.